Wagner H - Search Results

1

Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society.

Possinger K, Wagner H, Worst P, Queisser W, Bremer K, Rieche K, Klee M, Westerhausen M, Donhuijsen-Ant R, Fritze D, et al. Possinger K, et al. Among authors: wagner h. Onkologie. 1991 Feb;14(1):31-4. doi: 10.1159/000216941. Onkologie. 1991. PMID: 2057172 Clinical Trial.

2

Second-line treatment of advanced colorectal cancer with a weekly simultaneous 24-hour infusion of 5-fluorouracil and sodium-folinate: a multicentre phase II trial.

Kuhfahl J, Steinbrecher C, Wagner T, Wagner H, Fritze D, Link H, Schulte F, Pichlmeier U, Kreuser ED. Kuhfahl J, et al. Among authors: wagner t, wagner h. Onkologie. 2004 Oct;27(5):449-54. doi: 10.1159/000080365. Onkologie. 2004. PMID: 15585974 Clinical Trial.

3

Lonidamine in high-risk breast cancer patients.

Possinger K, Wagner H, Kovacs S, Flath B, Classen S, Wilmanns W. Possinger K, et al. Among authors: wagner h. Semin Oncol. 1991 Apr;18(2 Suppl 4):58-61. Semin Oncol. 1991. PMID: 2031199 Clinical Trial.

4

Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.

Wagner H, Possinger K, Bremer K, Donhujsen-Ant R, Peukert M, Queisser W. Wagner H, et al. Cancer Treat Rep. 1987 Feb;71(2):209-10. Cancer Treat Rep. 1987. PMID: 3802118 No abstract available.

5

Treatment toxicity reduction: breast cancer.

Possinger K, Wagner H, Langecker P, Wilmanns W. Possinger K, et al. Among authors: wagner h. Cancer Treat Rev. 1987 Dec;14(3-4):263-74. doi: 10.1016/0305-7372(87)90017-x. Cancer Treat Rev. 1987. PMID: 3326666 Review.

6

Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.

Stahl M, Schmoll E, Becker H, Schlichter A, Hoffmann L, Wagner H, Possinger K, Müller W, Köllermann M, Weidenhammer W, et al. Stahl M, et al. Among authors: wagner h. Semin Oncol. 1991 Apr;18(2 Suppl 4):33-7. Semin Oncol. 1991. PMID: 2031196 Clinical Trial.

7

Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study.

Höffken K, Jonat W, Possinger K, Kölbel M, Kunz T, Wagner H, Becher R, Callies R, Friederich P, Willmanns W, et al. Höffken K, et al. Among authors: wagner h. J Clin Oncol. 1990 May;8(5):875-80. doi: 10.1200/JCO.1990.8.5.875. J Clin Oncol. 1990. PMID: 2185341 Clinical Trial.

8

[Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy].

Possinger K, Wagner H, Langecker P, Schmid L, Willich S, Wilmanns W. Possinger K, et al. Among authors: wagner h. Fortschr Med. 1987 Jul 30;105(22):421-4. Fortschr Med. 1987. PMID: 2958397 German. No abstract available.

9

[Prognostic factors in adenocarcinoma of the kidney].

Possinger K, Wagner H, Beck R, Staebler A, Schmid L, Vollmann B, Wilmanns W. Possinger K, et al. Among authors: wagner h. Fortschr Med. 1987 Apr 20;105(11):204-8. Fortschr Med. 1987. PMID: 3596430 German. No abstract available.

10

Erlotinib in patients with previously irradiated, recurrent brain metastases from non-small cell lung cancer: two case reports.

von Pawel J, Wagner H, Duell T, Poellinger B. von Pawel J, et al. Among authors: wagner h. Onkologie. 2008 Mar;31(3):123-6. doi: 10.1159/000113928. Epub 2008 Feb 20. Onkologie. 2008. PMID: 18322416 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,006 results

Search Page

Filters